BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20616547)

  • 21. Sodium gradient: a tool to individualize dialysate sodium prescription in chronic hemodialysis patients?
    Penne EL; Sergeyeva O
    Blood Purif; 2011; 31(1-3):86-91. PubMed ID: 21228573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study.
    Sayarlioglu H; Erkoc R; Tuncer M; Soyoral Y; Esen R; Gumrukcuoglu HA; Dogan E; Sayarlioglu M
    Ren Fail; 2007; 29(2):143-6. PubMed ID: 17365927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two variable sodium profiles and adverse effects during hemodialysis: a randomized crossover study.
    Meira FS; Figueiredo AE; Zemiarcki J; Pacheco J; Poli-de-Figueiredo CE; d'Avila DO
    Ther Apher Dial; 2010 Jun; 14(3):328-33. PubMed ID: 20609187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of strict volume control on cognitive functions in chronic hemodialysis patients.
    Dogukan A; Guler M; Yavuzkir MF; Tekatas A; Poyrazoglu OK; Aygen B; Gunal AI; Yoldas TK
    Ren Fail; 2009; 31(8):641-6. PubMed ID: 19814630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.
    Kayikcioglu M; Tumuklu M; Ozkahya M; Ozdogan O; Asci G; Duman S; Toz H; Can LH; Basci A; Ok E
    Nephrol Dial Transplant; 2009 Mar; 24(3):956-62. PubMed ID: 19004849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients.
    Moret K; Aalten J; van den Wall Bake W; Gerlag P; Beerenhout C; van der Sande F; Leunissen K; Kooman J
    Nephrol Dial Transplant; 2006 Jan; 21(1):138-44. PubMed ID: 16144849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volume expansion and sodium balance in peritoneal dialysis patients. Part II: Newer insights in management.
    Khandelwal M; Kothari J; Krishnan M; Liakopoulos V; Tziviskou E; Sahu K; Chatalalsingh C; Bargman J; Oreopoulos D
    Adv Perit Dial; 2003; 19():44-52. PubMed ID: 14763033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluid dynamics during hemodialysis in relationship to sodium gradient between dialysate and plasma.
    Sarkar SR; Wystrychowski G; Zhu F; Usvyat LA; Kotanko P; Levin NW
    ASAIO J; 2007; 53(3):339-42. PubMed ID: 17515726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary management of patients with diabetes treated by hemodialysis.
    Davis M; Comty C; Shapiro F
    J Am Diet Assoc; 1979 Sep; 75(3):265-9. PubMed ID: 469138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interdialytic weight gain and ultrafiltration rate in hemodialysis: lessons about fluid adherence from a national registry of clinical practice.
    Lindberg M; Prütz KG; Lindberg P; Wikström B
    Hemodial Int; 2009 Apr; 13(2):181-8. PubMed ID: 19432692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can chronic volume overload be recognized and prevented in hemodialysis patients? Use of a restricted-salt diet.
    Chazot C
    Semin Dial; 2009; 22(5):482-6. PubMed ID: 19744154
    [No Abstract]   [Full Text] [Related]  

  • 32. Body fluid composition in chronic renal failure.
    Bauer JH; Brooks CS
    Clin Nephrol; 1981 Sep; 16(3):114-8. PubMed ID: 7296968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment.
    Charra B; Chazot C
    Nephron Physiol; 2003; 93(4):p94-101. PubMed ID: 12759570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teaching nutritional management to children on chronic hemodialysis.
    Spinozzi NS
    J Am Diet Assoc; 1979 Aug; 75(2):157-9. PubMed ID: 458082
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biological adequacy--what does it mean?].
    Kes P; Basić-Jukić N; Brunetta B
    Acta Med Croatica; 2004; 58(1):1-4. PubMed ID: 15125386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification.
    Zsom L; Zsom M; Fulop T; Flessner MF
    Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Importance of the residual renal function in hemodialysis patients].
    Rodríguez Benítez P; Gómez Campderá FJ
    Nefrologia; 2002; 22(2):98-103. PubMed ID: 12085429
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
    Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
    Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.